Atlas Trials

Pioglitazone, Body Composition,Insulin Sensitivity and Protein Metabolism in ESRD

Clinical trial NCT01253928 · UNKNOWN

Trial details

NCT number
NCT01253928
Sponsor
Centre Hospitalier Universitaire Vaudois
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
ESRD
Start date
2007-03-01
Primary completion
2011-06-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.